Literature DB >> 7641504

Direct effect of calcitriol on the regulation of parathyroid hormone secretion in a case of pseudo-hypoparathyroidism (a 24-month follow-up study).

P Giraud1, M Audran, V Rohmer, P Jallet, M F Basle, C Bregeon, J C Bigorgne.   

Abstract

The diagnosis of pseudohypoparathyroidism with osteitis fibrosa was made in a 51-year-old woman on the basis of hypocalcaemia, elevated plasma PTH (1-84) and blunted cAMP response to hPTH infusion. Radiologically, widespread signs of hyperparathyroidism were observed and quantitative histomorphometry confirmed the increased bone cellular turnover. Treatment with calcitriol (1,25 dihydroxyvitamin D3) induced a dramatic improvement of bone lesions. During treatment PTH (1-84) normalized with high dosage of calcitriol in spite of low or subnormal levels of serum calcium, and subsequently increased for each reduction of calcitriol dosage despite normal calcium levels. Our observations support a major and direct effect of 1,25 dihydroxyvitamin D3 on the regulation of parathyroid secretion of parathyroids glands.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7641504     DOI: 10.1007/bf02208341

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  23 in total

1.  Pseudohypoparathyroidism. Disappearance of the resistance to parathyroid extract during treatment with vitamin D.

Authors:  W Stögmann; J A Fischer
Journal:  Am J Med       Date:  1975-07       Impact factor: 4.965

2.  A rapid assay for 25-OH-vitamin D3 without preparative chromatography.

Authors:  R E Belsey; H F DeLuca; J T Potts
Journal:  J Clin Endocrinol Metab       Date:  1974-06       Impact factor: 5.958

3.  Pseudohypoparathyroidism: responsiveness to parathyroid extract induced by vitamin D2 therapy.

Authors:  S M Suh; D Fraser; S W Kooh
Journal:  J Clin Endocrinol Metab       Date:  1970-05       Impact factor: 5.958

4.  Influence of vitamin D on parathyroid function in the elderly.

Authors:  J M Quesada; W Coopmans; B Ruiz; P Aljama; I Jans; R Bouillon
Journal:  J Clin Endocrinol Metab       Date:  1992-08       Impact factor: 5.958

5.  Dissociation between the effects of endogenous parathyroid hormone on adenosine 3',5'-monophosphate generation and phosphate reabsorption in hypocalcemia due to vitamin D depletion: an acquired disorder resembling pseudohypoparathyroidism type II.

Authors:  D S Rao; A M Parfitt; M Kleerekoper; B S Pumo; B Frame
Journal:  J Clin Endocrinol Metab       Date:  1985-08       Impact factor: 5.958

Review 6.  Synthetic human parathyroid hormone 1-34 fragment for diagnostic testing.

Authors:  L E Mallette
Journal:  Ann Intern Med       Date:  1988-11-15       Impact factor: 25.391

Review 7.  Regulation of parathyroid hormone secretion.

Authors:  S L Pocotte; G Ehrenstein; L A Fitzpatrick
Journal:  Endocr Rev       Date:  1991-08       Impact factor: 19.871

8.  Pseudoidiopathic hypoparathyroidism. Hypoparathyroidism with ineffective parathyroid hormone.

Authors:  M L Nusynowitz; M H Klein
Journal:  Am J Med       Date:  1973-11       Impact factor: 4.965

9.  A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies.

Authors:  T A Reinhardt; R L Horst; J W Orf; B W Hollis
Journal:  J Clin Endocrinol Metab       Date:  1984-01       Impact factor: 5.958

10.  Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.

Authors:  J Silver; T Naveh-Many; H Mayer; H J Schmelzer; M M Popovtzer
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

View more
  1 in total

1.  Bone mineral density in pseudohypoparathyroidism type 1a.

Authors:  Dominique N Long; Michael A Levine; Emily L Germain-Lee
Journal:  J Clin Endocrinol Metab       Date:  2010-07-07       Impact factor: 5.958

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.